Austin, Texas (PRWEB) May 12, 2014
The Pennsylvania state court will hold a meeting on Tuesday, May 13th to discuss Risperdal lawsuits related to male gynecomastia and other side effects, Hissey Kientz, LLP reports. According to court documents, nearly 400 Risperdal lawsuits have been filed in a Mass Tort litigation underway in Pennsylvania's Philadelphia Court of Common Pleas. (Risperdal Litigation, case number 100300296)
The National Center for Biotechnology Information defines gynecomastia as the enlargement of breast tissue in males. An estimated 10%-25% of gynecomastia cases result from the use of medications. Side effects from gynecomastia can include swollen breast gland tissue, breast tenderness and lactation in one or both breasts.*
A 2006 study published in the Journal of Clinical Psychopharmacology reported that adolescents who took Risperdal exhibited significantly high levels of the hormone prolactin, which stimulates milk production and breast development. High levels of prolactin can lead to gynecomastia for men.**
A 2009 study published in the Journal of Child and Adolescent Psychopharmacology found that elevated prolactin levels from Risperdal use could persist for two years.***
Patients who have experienced gynecomastia after using Risperdal may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals experiencing breast growth from Risperdal, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa and Effexor, problems with transvaginal mesh, Stryker, DePuy, and Biomet hip replacements, GranuFlo acid concentrates, Mirena IUDs and other defective drugs and medical devices.